Description
Sofia® 2 Flu + SARS Antigen FIA
The Sofia 2 Flu + SARS Antigen fluorescent immunoassay (FIA) uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from influenza A and influenza B, and SARS-CoV-2. The Sofia 2 Flu + SARS Antigen FIA with the Sofia 2 analyzer provides automated and objective results in 15 minutes, allowing for testing of patients suspected of influenza A, influenza B, and COVID-19/2019-nCoV at the point of care.
Healthcare professionals can purchase the Sofia® 2 Flu + SARS Antigen FIA through select authorized distributors.
Catalog number: 20377 (U.S. nasal swab)
Kits/Case size: 25 kits per package, 12 packages per case.
Catalog number: 20380 (XUS)
Kits/Case size: 25 kits per package, 12 packages per case.
Specifications:
Product specifications | |
Time to results | 15 minutes |
Sample type | Direct: Nasal swab, nasopharyngeal swab |
Kit storage conditions | Room temperature (15 °C to 35 °C / 59 °F to 86 °F) |
PPA (sensitivity) | Influenza A: NS - 90%, NPS - 97.1% Influenza B: NS - 89%, NPS - 90% SARS-CoV-2: 95.2% |
NPA (specificity) | Influenza A: NS - 95%, NPS - 94.6% Influenza B: NS - 96%, NPS - 97% SARS-CoV-2: 100% |
CLIA complexity | Waived* |
Features & benefits:
- One sample, three results mean time savings, material conservation, and patient comfort.
- Rapid results in 15 minutes to support efficient dispositioning of patients.
- Objective, accurate, reliable results without cross-reactivity to seasonal coronaviruses.